Category: united states

A double-bill from Digestive Diseases and Sciences, both for regurgitation — aka duplication

ddsComing back up?

Digestive Diseases and Sciences has retracted two papers for duplication.

The first paper, “Membrane-Bound Mucins and Mucin Terminal Glycans Expression in Idiopathic or Helicobacter pylori, NSAID Associated Peptic Ulcers,” was published in October 2012 by a group from Israel and the United States. It found that:

Cytoplasmic MUC17 staining was significantly decreased in the cases with idiopathic ulcer. The opposite was demonstrated for MUC1. This observation might be important, since different mucins with altered sialylation patterns likely differ in their protection efficiency against acid and pepsin.

But, as the retraction notice suggests, that much had been found before: Continue reading A double-bill from Digestive Diseases and Sciences, both for regurgitation — aka duplication

Quorum sensing paper retracted when new study suggests compounds weren’t what they seemed

plos oneThe authors of a paper on quorum sensing — in simple terms, how bacteria “talk” to one another — have retracted it after another group’s findings led them to discover that the mixture they used weren’t what they thought.

The refreshingly detailed retraction notice in PLOS ONE explains: Continue reading Quorum sensing paper retracted when new study suggests compounds weren’t what they seemed

Amid a legal dispute, journal downgrades a retraction to an expression of concern

cellcyclecoverThe journal Cell Cycle is expressing a “note” of concern about a 2012 paper by a former researcher at the University of Minnesota, who has claimed that her mentor at the institution was violating her copyright. It turns out the journal had briefly retracted the paper, but reversed itself with the expression of concern — a curious about-face that, in our experience, often indicates the work of lawyers.

That seems to be the case here, too.

The article, “Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes,” was already the subject of an erratum, available here:

Continue reading Amid a legal dispute, journal downgrades a retraction to an expression of concern

Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper

cell cloningCell is looking into whether the authors of a widely hailed study published last week claiming to have turned human skin cells into embryonic stem cells manipulated images inappropriately, Retraction Watch has learned.

The potential image problems came to light on PubPeer, a site designed to allow for post-publication peer review. A commenter, identified as Peer1, identified “several examples of image reuse which might be of interest to PubPeer members and readers:” Continue reading Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper

Journal expresses concern over flawed multiple sclerosis treatment guideline

neurology may13coverThe journal Neurology has issued an Expression of Concern over recommendations it published earlier this year regarding the treatment of multiple sclerosis.

The journal’s website received multiple comments from clinicians expressing their own concern about the flawed recommendation, which was published as part of a paper titled “The American Academy of Neurology’s Top Five Choosing Wisely recommendations.” The problematic item was number 4: Continue reading Journal expresses concern over flawed multiple sclerosis treatment guideline

A new record? 27-plus years later, a notice of redundant publication

royal society bA 1984 paper in Philosophical Transactions of The Royal Society B is now subject to a notice of redundant publication because a lot of it had been published in Cell the same year.

Whether 28 years — 27 years and 9 months, to be precise — is any kind of official record is unclear, since we haven’t really kept track of notices of redundant publication. It would, however, beat the record for longest time between publication and retraction, 27 years and one month.

Here’s the notice, which ran in September of last year but just came to our attention: Continue reading A new record? 27-plus years later, a notice of redundant publication

Paper by Bristol-Myers Squibb researchers retracted for “unsolved legal reasons”

applied micro biotechA group of researchers at Bristol-Myers Squibb has had a paper retracted for reasons we can’t quite figure out.

All the notice for “Simultaneous expression of antibody light and heavy chains in Pichia pastoris: improving retransformation outcome by linearizing vector at a different site,” published in Applied Microbiology and Biotechnology, says is: Continue reading Paper by Bristol-Myers Squibb researchers retracted for “unsolved legal reasons”

Two Expressions of Concern in Blood for MD Anderson’s Aggarwal, who has threatened to sue Retraction Watch

aggarwalBharat Aggarwal, the MD Anderson researcher who has threatened to sue us while under investigation by his institution for alleged misconduct, now has two Expressions of Concern in addition to two corrections and two unexplained withdrawals.

Both of the papers were published in Blood. The Expression of Concern for “Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway,” reads: Continue reading Two Expressions of Concern in Blood for MD Anderson’s Aggarwal, who has threatened to sue Retraction Watch

One-too-many authors scuttles paper on mouse metabolism

reg pepcoverRegulatory Peptides is retracting a 2010 paper by a group of five authors in China and one in Texas — and the presence of that last one was the problem.

The article, “Erythropoietin as a possible mechanism for the effects of intermittent hypoxia on bodyweight, serum glucose and leptin in mice,” had as its last (dare we say, senior) author Susan T. Howard, a mycobacterium expert at the University of Texas Health Science Center in Tyler. Trouble was, Howard disavowed any role in the paper.

According to the retraction notice: Continue reading One-too-many authors scuttles paper on mouse metabolism

Diabetes paper retracted for “misgrouping errors” that remain under investigation

diabetesA group of researchers at the University of Minnesota have retracted a paper in Diabetes for image problems, but exactly what happened is still under investigation.

Here’s the notice: Continue reading Diabetes paper retracted for “misgrouping errors” that remain under investigation